Michele Keough Joins Metri Bio as Chief Operating Officer
Metri Bio has appointed Michele Keough as Chief Operating Officer, bringing more than two decades of experience building and scaling biotechnology organizations. Across leadership roles in research strategy, operations, and alliance management, Michele has helped guide complex therapeutic programs from early development through organizational growth. Most recently, Michele served in senior leadership roles at Moderna, […]
Metri Bio CEO Ashley Abel Selected for the 2026 Termeer Fellowship
Metri Bio CEO and co-founder Ashley Abel has been selected for the 2026 Termeer Fellowship, a highly competitive leadership program for emerging life sciences CEOs. Through mentorship, peer learning, and access to an experienced network of biotechnology leaders, the fellowship supports founders as they scale companies working to address major unmet needs in healthcare. Ashley […]
Metri Bio’s CEO, Ashley Abel, selected for Forbes 30 Under 30
Metri Bio CEO and co-founder Ashley Abel has been named to the Forbes 30 Under 30 list in recognition of her work advancing new therapeutic approaches for endometriosis and other endometrial diseases. Read on forbes
Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics​
Metri Bio has raised $5 million in an oversubscribed pre-seed financing round led by Pillar VC, with participation from Pace Ventures, Slocum Management, Navec Investments, and angel investors. The Boston-based biotechnology company is developing therapies for endometrial diseases. The Boston-based company emerged from stealth with the funding announcement. Metri Bio was co-founded by Berna Sozen, […]